Viridian Therapeutics, Inc. (VRDN)
14.72
-0.16
(-1.08%)
USD |
NASDAQ |
Apr 16, 15:38
Viridian Therapeutics Research and Development Expense (Quarterly) : 89.09M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 2.141M |
| Amgen, Inc. | 2.151B |
| Boston Scientific Corp. | 569.00M |
| Plus Therapeutics, Inc. | 2.941M |
| Nutriband, Inc. | 0.4571M |